Multiple Modes of Impulsivity in Parkinson's Disease
暂无分享,去创建一个
James B. Rowe | Trevor W. Robbins | Timothy Rittman | T. Robbins | J. Rowe | T. Rittman | C. Nombela | Cristina Nombela
[1] A. Bonnet,et al. [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.
[2] Jan Peters,et al. The neural mechanisms of inter-temporal decision-making: understanding variability , 2011, Trends in Cognitive Sciences.
[3] R. Carpenter,et al. Saccadometry: A novel clinical tool for quantification of the motor effects of subthalamic nucleus stimulation in Parkinson's disease , 2009, Experimental Neurology.
[4] Emma S. J. Robinson,et al. Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats , 2009, Psychopharmacology.
[5] D. Royall,et al. The FAB: A frontal assessment battery at bedside , 2001, Neurology.
[6] Andrew T. Morgan,et al. Behavioral/systems/cognitive Striatal Dopamine D 2 /d 3 Receptors Mediate Response Inhibition and Related Activity in Frontostriatal Neural Circuitry in Humans Impulsive Behavior Is Thought to Reflect a Traitlike Characteristic That Can Have Broad Consequences for an Individual's Success and Well-be , 2022 .
[7] R. Barker,et al. The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease , 2010, Neurobiology of Aging.
[8] C. Frith,et al. The functional anatomy of verbal initiation and suppression using the Hayling Test , 1997, Neuropsychologia.
[9] R. Dolan,et al. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans , 2006, Nature.
[10] M. Bouvard,et al. Étude du tempérament et de la personnalité chez l’enfant souffrant d’un trouble déficit d’attention/hyperactivité (TDAH) , 2012 .
[11] F. Fera,et al. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease , 2007, Brain Research Bulletin.
[12] Andrew J Lees,et al. Intact Reward Learning but Elevated Delay Discounting in Parkinson's Disease Patients With Impulsive-Compulsive Spectrum Behaviors , 2010, Neuropsychopharmacology.
[13] Masaru Mimura,et al. Decision making in Parkinson's disease: Analysis of behavioral and physiological patterns in the Iowa gambling task , 2008, Movement disorders : official journal of the Movement Disorder Society.
[14] M. S. Lee,et al. The effect of age on motor deficits and cerebral glucose metabolism of Parkinson’s disease , 2011, Acta neurologica Scandinavica.
[15] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[16] E. Barratt. Impulsiveness and aggression. , 1994 .
[17] B. Averbeck,et al. Novelty seeking behaviour in Parkinson's disease , 2011, Neuropsychologia.
[18] U. Bonuccelli,et al. Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management. , 2009, Parkinsonism & related disorders.
[19] Rebecca Elliott,et al. The Effect of Citalopram Pretreatment on Neuronal Responses to Neuropsychological Tasks in Normal Volunteers: An fMRI Study , 2005, Neuropsychopharmacology.
[20] Michael J. Frank,et al. Hold Your Horses: Impulsivity, Deep Brain Stimulation, and Medication in Parkinsonism , 2007, Science.
[21] P. Krack,et al. Deep brain stimulation: from neurology to psychiatry? , 2010, Trends in Neurosciences.
[22] E. Petrusa,et al. A Multicenter Study to Provide Evidence of Construct Validity in a Computer-Based Outcome Measure of Neurology Clinical Skills , 2005, Academic medicine : journal of the Association of American Medical Colleges.
[23] T. Robbins,et al. A neuropsychological comparison of obsessive–compulsive disorder and trichotillomania , 2007, Neuropsychologia.
[24] M. Rieger,et al. Inhibition of ongoing responses in patients with Parkinson’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[25] R. H. S. Carpenter,et al. Neural computation of log likelihood in control of saccadic eye movements , 1995, Nature.
[26] M. Zapata,et al. [Risk of pathological gambling, Associated factors and mental disorders in youth from Medellin - Colombia]. , 2011, Adicciones.
[27] Dawn M Eagle,et al. Contrasting Roles for Dopamine D1 and D2 Receptor Subtypes in the Dorsomedial Striatum but Not the Nucleus Accumbens Core during Behavioral Inhibition in the Stop-Signal Task in Rats , 2011, The Journal of Neuroscience.
[28] F. Meneghello,et al. Brain volume changes in Parkinson's disease and their relationship with cognitive and behavioural abnormalities , 2011, Journal of the Neurological Sciences.
[29] S. Calugi,et al. Effects of cognitive-behavioral therapy on Eating Disorders: Neurotransmitter secretory response to treatment , 2010, Psychoneuroendocrinology.
[30] Kaarin J Anstey,et al. Hippocampal volume is positively associated with behavioural inhibition (BIS) in a large community-based sample of mid-life adults: the PATH through life study. , 2008, Social cognitive and affective neuroscience.
[31] K. Chaudhuri,et al. The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[32] Karl J. Friston,et al. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study. , 1999, Brain : a journal of neurology.
[33] B. Wollschlaeger. Impulse Control Disorders: A Clinician’s Guide to Understanding and Treating Behavioral Addictions , 2008 .
[34] Viviane Pouthas,et al. Effects of internal clock and memory disorders on duration reproductions and duration productions in patients with Parkinson’s disease , 2005, Brain and Cognition.
[35] W. Dauer,et al. Parkinson's Disease Mechanisms and Models , 2003, Neuron.
[36] T. Braver,et al. Anterior cingulate cortex and response conflict: effects of response modality and processing domain. , 2001, Cerebral Cortex.
[37] J. Kenemans,et al. Methylphenidate Restores Link Between Stop-Signal Sensory Impact and Successful Stopping in Adults with Attention-Deficit/Hyperactivity Disorder , 2009, Biological Psychiatry.
[38] John C. Rothwell,et al. The right dorsolateral prefrontal cortex is essential in time reproduction: an investigation with repetitive transcranial magnetic stimulation , 2004, Experimental Brain Research.
[39] C. Kruse,et al. Modulation of midbrain dopamine neurotransmission by serotonin, a versatile interaction between neurotransmitters and significance for antipsychotic drug action. , 2006, Current neuropharmacology.
[40] Michael J. Frank,et al. Dynamic Dopamine Modulation in the Basal Ganglia: A Neurocomputational Account of Cognitive Deficits in Medicated and Nonmedicated Parkinsonism , 2005, Journal of Cognitive Neuroscience.
[41] T. Robbins,et al. Serotonin Depletion Impairs Waiting but not Stop-Signal Reaction Time in Rats: Implications for Theories of the Role of 5-HT in Behavioral Inhibition , 2009, Neuropsychopharmacology.
[42] T. Münte,et al. Intertemporal choice in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[43] T. Boult,et al. The eyes have it , 2003, WBMA '03.
[44] Y. Agid,et al. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease , 1983, Brain Research.
[45] Y. D. Werf,et al. Parkinson’s disease-related disorders in the impulsive-compulsive spectrum , 2008, Journal of Neurology.
[46] Melissa J. Allman,et al. Pathophysiological distortions in time perception and timed performance. , 2012, Brain : a journal of neurology.
[47] A. Antonini,et al. Functional abnormalities underlying pathological gambling in Parkinson disease. , 2008, Archives of neurology.
[48] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[49] Tim Shallice,et al. The Hayling and Brixton Tests , 1997 .
[50] P. Moberg,et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. , 2006, Archives of neurology.
[51] J. Ridley. Studies of Interference in Serial Verbal Reactions , 2001 .
[52] G. Logan,et al. Converging Evidence for a Fronto-Basal-Ganglia Network for Inhibitory Control of Action and Cognition , 2007, The Journal of Neuroscience.
[53] Yasuyuki Taki,et al. Regional gray and white matter volume associated with Stroop interference: Evidence from voxel-based morphometry , 2012, NeuroImage.
[54] Trevor W Robbins,et al. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. , 2006, The American journal of psychiatry.
[55] T. Robbins,et al. Catechol O-Methyltransferase val158met Genotype Influences Frontoparietal Activity during Planning in Patients with Parkinson's Disease , 2007, The Journal of Neuroscience.
[56] Daniel Weintraub,et al. Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease , 2007, Nature Clinical Practice Neurology.
[57] T. Robbins,et al. The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks , 2008, Psychopharmacology.
[58] S. Mobini,et al. Effect of central 5-hydroxytryptamine depletion on inter-temporal choice: a quantitative analysis , 2000, Psychopharmacology.
[59] R. Barker,et al. The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[60] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[61] D. Eckstein,et al. Parkinson's disease and dopaminergic therapy—differential effects on movement, reward and cognition , 2008, Brain : a journal of neurology.
[62] E. Esposito,et al. Serotonin-dopamine interaction: electrophysiological evidence. , 2008, Progress in brain research.
[63] M. Rietschel,et al. Adolescent impulsivity phenotypes characterized by distinct brain networks , 2012, Nature Neuroscience.
[64] Catalin V. Buhusi,et al. Effect of clozapine on interval timing and working memory for time in the peak-interval procedure with gaps , 2007, Behavioural Processes.
[65] Julio Acosta-Cabronero,et al. Social cognitive deficits and their neural correlates in progressive supranuclear palsy , 2012, Brain : a journal of neurology.
[66] John R Hodges,et al. The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening , 2006, International journal of geriatric psychiatry.
[67] T. Robbins,et al. Impulsivity, Compulsivity, and Top-Down Cognitive Control , 2011, Neuron.
[68] Timothy E. J. Behrens,et al. Dissociable Reward and Timing Signals in Human Midbrain and Ventral Striatum , 2011, Neuron.
[69] S. Houle,et al. Stimulation of the subthalamic nucleus and impulsivity: Release your horses , 2009, Annals of neurology.
[70] Marjan Jahanshahi,et al. Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson’s disease , 2011, Experimental Brain Research.
[71] A. Beck,et al. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation , 1988 .
[72] T. Robbins,et al. Methylphenidate (‘Ritalin’) can Ameliorate Abnormal Risk-Taking Behavior in the Frontal Variant of Frontotemporal Dementia , 2006, Neuropsychopharmacology.
[73] P. Barone,et al. Impulsivity and compulsivity in drug‐naïve patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[74] Jae-on Kim,et al. Introduction to Factor Analysis , 1978 .
[75] L. Montoya,et al. Riesgo de Juego Patológico. Factores y trastornos mentales asociados en jóvenes de Medellín - Colombia , 2011 .
[76] M Vidailhet,et al. Mixing pro- and antisaccades in patients with parkinsonian syndromes. , 2006, Brain : a journal of neurology.
[77] J. Gibbon,et al. Scalar expectancy theory and peak-interval timing in humans. , 1998, Journal of experimental psychology. Animal behavior processes.
[78] Emanuele Lo Gerfo,et al. Impaired reproduction of second but not millisecond time intervals in Parkinson's disease , 2008, Neuropsychologia.
[79] C. Huang-Pollock,et al. Examining Relationships Between Executive Functioning and Delay Aversion in Attention Deficit Hyperactivity Disorder , 2011, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.
[80] W. Schultz. Book Review: Reward Signaling by Dopamine Neurons , 2001, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[81] R. Barker,et al. “The eyes have it”. Saccadometry and Parkinson's disease , 2009, Experimental Neurology.
[82] T. Robbins,et al. Prefrontal and Monoaminergic Contributions to Stop-Signal Task Performance in Rats , 2011, The Journal of Neuroscience.
[83] M. Leboyer,et al. Prefrontal cortex dysfunction in patients with suicidal behavior , 2006, Psychological Medicine.
[84] John Monahan,et al. Violence and mental disorder: Developments in risk assessment. , 1994 .
[85] K. Kirby,et al. Delay-discounting probabilistic rewards: Rates decrease as amounts increase , 1996, Psychonomic bulletin & review.
[86] M J Stokes,et al. EEG-based communication: a pattern recognition approach. , 2000, IEEE transactions on rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society.
[87] A. Antonini,et al. The relationship between impulsivity and impulse control disorders in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[88] T. Braver,et al. Anterior Cingulate Cortex and Response Conflict : Effects of Response Modality and Processing Domain , 2022 .
[89] D. Marazziti,et al. Decreased Density of the Platelet Serotonin Transporter in Pathological Gamblers , 2008, Neuropsychobiology.
[90] Lynn Rochester,et al. Gait variability in Parkinson’s disease: an indicator of non-dopaminergic contributors to gait dysfunction? , 2011, Journal of Neurology.
[91] T. Roth,et al. Sleepiness in Parkinson's disease: A controlled study , 2003, Movement disorders : official journal of the Movement Disorder Society.
[92] T. Robbins,et al. Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task , 2013, Psychopharmacology.
[93] A. Rotondo,et al. Clozapine for medication‐related pathological gambling in Parkinson disease , 2010, Movement Disorders.
[94] E. Barratt,et al. Anxiety and Impulsiveness Related to Psychomotor Efficiency , 1959 .
[95] Myrna B. Shure,et al. The Impulsive client : theory, research, and treatment , 1993 .
[96] D. Marazziti,et al. Male axillary extracts modify the affinity of the platelet serotonin transporter and impulsiveness in women , 2010, Physiology & Behavior.
[97] A. Meyer-Lindenberg,et al. Antiserotonergic antipsychotics are associated with obsessive–compulsive symptoms in schizophrenia , 2011, Psychological Medicine.
[98] W. Meck. Neuropharmacology of timing and time perception. , 1996, Brain research. Cognitive brain research.
[99] Hiroyuki Nakahara,et al. Internal-Time Temporal Difference Model for Neural Value-Based Decision Making , 2010, Neural Computation.
[100] Roger A. Barker,et al. White matter pathology in Parkinson's disease: The effect of imaging protocol differences and relevance to executive function , 2012, NeuroImage.
[101] R. Elliott,et al. Playing it safe but losing anyway—Serotonergic signaling of negative outcomes in dorsomedial prefrontal cortex in the context of risk-aversion , 2013, European Neuropsychopharmacology.
[102] A. Wagner,et al. Cognitive control and right ventrolateral prefrontal cortex: reflexive reorienting, motor inhibition, and action updating , 2011, Annals of the New York Academy of Sciences.
[103] Antonio P. Strafella,et al. Impulsivity and Parkinson's disease: More than just disinhibition , 2011, Journal of the Neurological Sciences.
[104] J. Patton,et al. Fifty years of the Barratt Impulsiveness Scale: An update and review , 2009 .
[105] I. McKeith,et al. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. , 2004, Brain : a journal of neurology.
[106] R. Carpenter,et al. Saccadic abnormalities in frontotemporal dementia , 2012, Neurology.
[107] J. Gibbon,et al. Differential effects of auditory and visual signals on clock speed and temporal memory. , 2000, Journal of experimental psychology. Human perception and performance.
[108] M. Hallett,et al. Mechanisms Underlying Dopamine-Mediated Reward Bias in Compulsive Behaviors , 2010, Neuron.
[109] A. Lawrence,et al. Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease , 2005, Neurology.
[110] A. Damasio,et al. Insensitivity to future consequences following damage to human prefrontal cortex , 1994, Cognition.
[111] T. Robbins,et al. Atomoxetine Modulates Right Inferior Frontal Activation During Inhibitory Control: A Pharmacological Functional Magnetic Resonance Imaging Study , 2009, Biological Psychiatry.
[112] B. Dubois,et al. Motivation, reward, and Parkinson’s disease: influence of dopatherapy , 2002, Neuropsychologia.
[113] A. Lang,et al. Amantadine use associated with impulse control disorders in Parkinson disease in cross‐sectional study , 2010, Annals of neurology.
[114] Felipe Fregni,et al. Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression , 2005, Movement disorders : official journal of the Movement Disorder Society.
[115] D. Goldstein,et al. Catechols in post‐mortem brain of patients with Parkinson disease , 2011, European journal of neurology.
[116] T. Robbins,et al. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans , 2003, Nature Neuroscience.
[117] G. M. Halliday,et al. Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease , 1990, Brain Research.
[118] S. Faraone,et al. Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity. , 2006, The Journal of clinical psychiatry.
[119] Sylvia M. L. Cox,et al. Tryptophan Depletion Disrupts the Motivational Guidance of Goal-Directed Behavior as a Function of Trait Impulsivity , 2005, Neuropsychopharmacology.
[120] M Tagliati,et al. Subthalamic deep brain stimulation and impulse control in Parkinson’s disease , 2009, European journal of neurology.
[121] Diane C. Tsai. Recent Developments in Parkinson's Disease , 1986, The Yale Journal of Biology and Medicine.
[122] T. Robbins,et al. Reflection Impulsivity in Current and Former Substance Users , 2006, Biological Psychiatry.
[123] L. Clark. Decision-making during gambling: an integration of cognitive and psychobiological approaches , 2010, Philosophical Transactions of the Royal Society B: Biological Sciences.
[124] R. Carpenter,et al. Saccadic latency in Parkinson's disease correlates with executive function and brain atrophy, but not motor severity , 2011, Neurobiology of Disease.
[125] A. Turken,et al. Left inferior frontal gyrus is critical for response inhibition , 2008, BMC Neuroscience.
[126] Mark Hallett,et al. Impulse control disorders in Parkinson's disease: recent advances. , 2011, Current opinion in neurology.
[127] P. Cumming,et al. Molecular imaging and the neuropathologies of Parkinson's disease. , 2012, Current topics in behavioral neurosciences.
[128] S. Fahn. Unified Parkinson's Disease Rating Scale , 1987 .
[129] T. Robbins,et al. l-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease , 2003, Neuropsychologia.
[130] B. Averbeck,et al. Stroop test performance in impulsive and non impulsive patients with Parkinson's disease. , 2011, Parkinsonism & related disorders.
[131] Jae-On Kim,et al. Introduction to Factor Analysis: What It Is and How To Do It , 1978 .
[132] D. Brooks,et al. Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study , 2010, Neurobiology of Disease.
[133] T. Robbins,et al. Behavioral models of impulsivity in relation to ADHD: Translation between clinical and preclinical studies , 2006, Clinical psychology review.
[134] H. Lesieur,et al. The South Oaks Gambling Screen (SaGS): A New Instrument for the Identification of Pathological Gamblers , 2010 .
[135] Michael Hornberger,et al. Fronto-striatal atrophy correlates of inhibitory dysfunction in Parkinson's disease versus behavioural variant frontotemporal dementia , 2013, Cortex.
[136] W. Meck,et al. Neuroanatomical and Neurochemical Substrates of Timing , 2011, Neuropsychopharmacology.
[137] T. Robbins,et al. Inhibition and the right inferior frontal cortex , 2004, Trends in Cognitive Sciences.
[138] Erwan Bezard,et al. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders , 2009, The Lancet Neurology.
[139] Lori J. P. Altmann,et al. High-Level Language Production in Parkinson's Disease: A Review , 2011, Parkinson's disease.
[140] T. Robbins,et al. Similar Effects of the Selective Noradrenaline Reuptake Inhibitor Atomoxetine on Three Distinct Forms of Impulsivity in the Rat , 2008, Neuropsychopharmacology.
[141] A. Darzi,et al. Effect of Pharmacological Enhancement on the Cognitive and Clinical Psychomotor Performance of Sleep-Deprived Doctors: A Randomized Controlled Trial , 2012, Annals of surgery.
[142] Mark Hallett,et al. Impulsive choice and response in dopamine agonist-related impulse control behaviors , 2009, Psychopharmacology.